Kazia Therapeutics Limited (ADR) (KZIA) Live Share Price, Invest From India

Kazia Therapeutics Limited (ADR) Stock Performance

as on June 19, 2026 at 2:16 pm IST

Day's Low
Day's High
$13.32
Day's Price Range
$14.87
$13.86
3.90%
Downside
7.29%
Upside
52 Week's Low
52 Week's High
$4.86
52-Week Price Range
$17.40
$13.86
64.94%
Downside
25.54%
Upside

Kazia Therapeutics Limited (ADR) share price movements today

Previous Close: $14.25
Open: $14.62
Volume: 420.4K
Day's Low - High: $13.32 - $14.87
52 Week Low - High: $4.86 - $17.40

Kazia Therapeutics Limited (ADR) Historical Returns

1 Month Return: + 14.74 %
3 Month Return: + 75.22 %
1 Year Return: + 55.56 %
3 Year Return: -77.65 %
5 Year Return: -97.31 %

Kazia Therapeutics Limited (ADR) Stock Fundamentals & Key Indicators

Check Kazia Therapeutics Limited (ADR) market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$162.8M

EPS (TTM)

-0.017

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

PEG Ratio

1.0118

EBITDA

-17.8M

Revenue (TTM)

1.9M

Profit Margin

0.00%

Return On Equity TTM

-106.90%

Kazia Therapeutics Limited (ADR) vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Kazia Therapeutics Limited (ADR) with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Kazia Therapeutics Limited (ADR)	BUY	$162.8M	-97.31%	NA	0.00%	NA
Alnylam Pharmaceuticals Inc.	BUY	$37.7B	57.21%	71.21	12.55%	NA
Vertex Pharmaceuticals Inc.	BUY	$116.5B	140.42%	27.22	35.51%	NA
Regeneron Pharmaceuticals Inc.	BUY	$63.7B	13.39%	14.85	29.65%	0.58%

Stock Returns calculator for Kazia Therapeutics Limited (ADR) Stock including INR - Dollar returns

The Kazia Therapeutics Limited (ADR) stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Kazia Therapeutics Limited (ADR) investment value today

Current value as on today

₹1,69,761

Returns

₹69,761

(+69.76%)

Returns from Kazia Therapeutics Limited (ADR) Stock

₹55,556 (+55.56%)

Dollar Impact

₹14,206 (+14.21%)

Analyst Recommendation on Kazia Therapeutics Limited (ADR) Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Kazia Therapeutics Limited (ADR). Average target price of $25.97

Kazia Therapeutics Limited (ADR) Share Price Target

Get share price movements and forecasts by analysts on Kazia Therapeutics Limited (ADR).

What analysts predicted

46.63%UPSIDE

Target Price

$25.97

Current Price

$13.86

Analyzed by

7 Analysts

Target

$25.97

Kazia Therapeutics Limited (ADR) target price $25.97, a slight upside of 46.63% compared to current price of $13.86. According to 7 analysts rating.

Indian Investors' Interest in Kazia Therapeutics Limited (ADR) Stock

Search interest for Kazia Therapeutics Limited (ADR) Stock has decreased by -21% in the last 30 days, reflecting a downward trend in search activity.

Time period: May 20, 2026 to June 19, 2026

Change:-21% versus previous 30 day period

Kazia Therapeutics Limited (ADR) Quarterly Profit & Loss

All numbers in Millions USD

	Sep 2022	Mar 2023	Sep 2023	Dec 2023	Sep 2024	Dec 2024	Sep 2025
Total Revenue	-1	0	0	0	2	0	0
Gross Profit	-1	0	0	0	2	0	0
Operating Income	-25	-5	-10	-8	-19	-9	-4
EBITDA	-11	-4	-9	-7	-18	-8	-4
Interest Expense	4	-	-	-	-	-	-
Depreciation	-	-	-	-	-	-	-
Income Before Tax	-11	-3	-7	-8	-18	-10	-11
Income Tax Expense	0	0	0	0	0	0	-1
Net Income	-7	-2	-4	-5	-17	-10	-9
Net Profit Margin	407.56%	-1237257.55%	-687897.30%	-176470260.00%	-723.68%	-46899.11%	-50487.24%

Kazia Therapeutics Limited (ADR) Annual Profit & Loss

All numbers in Millions USD

	Jun 2016	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Total Revenue	3	6	0	0	0	11	0	0	1	0
Gross Profit	3	6	0	0	0	11	0	0	1	0
Operating Income	-12	-10	-12	-8	-12	-6	-25	-24	-28	-14
EBITDA	-11	-9	-10	-7	-11	-5	-23	-22	-26	-13
Interest Expense	-	0	-	2	0	5	0	-	-	-
Depreciation	-	1	1	1	1	1	1	1	1	0
Income Before Tax	-12	-10	-6	-10	-12	-8	-25	-20	-27	-22
Income Tax Expense	2	0	0	0	0	0	0	0	0	-1
Net Income	-8	-8	-4	-7	-8	-6	-17	-13	-17	-20
Net Profit Margin	-296.29%	-121.42%	-46071.10%	-656230.03%	-1261.75%	-55.46%	-250140.00%	-3687419.82%	-1160.23%	-49290.48%

Kazia Therapeutics Limited (ADR) Quarterly Cash Flow

All numbers in Millions USD

	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Sep 2024	Dec 2024	Sep 2025	Dec 2025
Net Income	-13	-3	-3	-6	-8	-17	-5	-9	-12
Operating Cash Flow	-8	-3	-3	-6	-6	-3	-4	-4	-9
Investing Cash Flow	7	-	-	-5	5	-	-	-	-
Financing Cash Flow	5	3	3	7	4	0	4	5	73
Change in Cash	4	0	0	-3	3	-1	0	1	65

Kazia Therapeutics Limited (ADR) Annual Cash Flow

All numbers in Millions USD

	Jun 2017	Jun 2018	Jun 2019	Jun 2020	Jun 2021	Jun 2022	Jun 2023	Jun 2024	Jun 2025
Net Income	-10	-6	-10	-12	-8	-25	-20	-26	-20
Operating Cash Flow	-11	-8	-6	-8	-9	-22	-15	-9	-13
Investing Cash Flow	-7	0	2	-2	-2	-2	-	-	-
Financing Cash Flow	0	3	3	12	28	3	12	5	15
Change in Cash	-18	-8	0	3	18	-20	-2	-3	2

Global Institutional Holdings in Kazia Therapeutics Limited (ADR)

Funds	Holdings
Balyasny Asset Management LLC	1.69%
Velan Capital Investment Management LP	1.18%
GAMMA Investing LLC	0.01%
Dauntless Investment Group, LLC	0%
Stonepine Capital Management Llc	3.02%

See all

Insights on Kazia Therapeutics Limited (ADR)

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Price Rise
In the last 3 months, KZIA stock has moved up by 75.2%
POSITIVE IMPACT
Best in 1 Year
In the last 1 year, KZIA has outperformed top 5 stocks with highest market-cap in its industry
NO EFFECT
Against Peers
In the last 3 years, Kazia Therapeutics Limited American Depositary Shares has experienced a drawdown of -77.6%, however Alnylam Pharmaceuticals, Inc. Common Stock resisted the overall trend and outperformed by 55.5%
NEGATIVE IMPACT
Revenue Fall
Revenue is down for the last 3 quarters, 2.48M → 19.71K (in $), with an average decrease of 55.3% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 2 quarters, -9.95M → -12.32M (in $), with an average decrease of 23.8% per quarter

About Kazia Therapeutics Limited (ADR)

Kazia Therapeutics Limited, together with its subsidiaries, operates as an oncology-focused biotechnology company in Israel. The company's lead development candidate is paxalisib, a small molecule, brain-penetrant inhibitor of the phosphoinositide-3-kinase (PI3K)/AKT/mammalian target of rapamycin (mTOR) pathway, which is in Phase II/III clinical trial for the treatment of glioblastoma; in Phase II trial to treat isocitrate dehydrogenase-mutant glioma, primary central nervous system (CNS) lymphoma, diffuse intrinsic pontine glioma, and brain metastases; and in pre-clinical studies to treat triple-negative breast cancer, as well as for the treatment of atypical rhabdoid/teratoid tumors. It also develops EVT801, a small-molecule selective inhibitor of vascular endothelial growth factor receptor 3 that is in Phase I clinical trial to treat advanced solid tumors and ovarian cancer. The company has collaborations with the Australian and New Zealand Children's Haematology/Oncology Group, Genentech Inc., Global Coalition for Adaptive Research, Vivesto AB, Simcere Pharmaceutical Group Ltd, Evotec SE, Sovargen Co., Ltd, and QIMR Berghofer Medical Research Institute. Kazia Therapeutics Limited was formerly known as Novogen Limited and changed its name to Kazia Therapeutics Limited in November 2017. Kazia Therapeutics Limited was incorporated in 1994 and is based in Sydney, Australia.

Organisation	Kazia Therapeutics Limited (ADR)
Headquarters	Three International Towers, Sydney, NSW, Australia, 2000
Industry	Biotechnology
CEO	Dr. John Edwin Friend II, M.D.
E-voting on shares	Click here to vote

Key Management of Kazia Therapeutics Limited (ADR)

Name	Title
Dr. John Edwin Friend II, M.D.	Chief Executive Officer
Ms. Elissa C. Hansen ACSA, B.Com., B.Comm, FCIS, Gad Dip ACG, GAI, GAIC	Company Secretary
Mr. Jeffrey Bonacorda	VP of Finance & Controller
Mr. James E. Levine	Chief Financial Officer
Dr. Sudha Rao	Chief Scientific Officer

FAQs

What is Kazia Therapeutics Limited (ADR) share price today?

Kazia Therapeutics Limited (ADR) share price today is $13.86 as on June 19, 2026 at 8:46 am IST at the close of the market. Kazia Therapeutics Limited (ADR) share today touched a day high of $14.87 and a low of $13.32.

What is the 52 week high and 52 week low for Kazia Therapeutics Limited (ADR) share?

Kazia Therapeutics Limited (ADR) share touched a 52 week high of $17.4 on December 8, 2025 and a 52 week low of $4.86 on February 12, 2026. Kazia Therapeutics Limited (ADR) stock price today i.e. June 19, 2026 at 8:46 am IST is closed at $13.86,which is 20.34% down from its 52 week high and 185.19% up from its 52 week low.

What is Kazia Therapeutics Limited (ADR)'s market capitalisation today?

Kazia Therapeutics Limited (ADR) market capitalisation is $0.00T as on June 19, 2026 at 8:46 am IST.

How to invest in Kazia Therapeutics Limited (ADR) Stock (KZIA) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Kazia Therapeutics Limited (ADR) on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Kazia Therapeutics Limited (ADR) Shares that will get you 0.1082 shares as per Kazia Therapeutics Limited (ADR) share price of $13.86 per share as on June 19, 2026 at 8:46 am IST.

What is the minimum amount required to buy Kazia Therapeutics Limited (ADR) Stock (KZIA) from India?

Indian investors can start investing in Kazia Therapeutics Limited (ADR) (KZIA) shares with as little as ₹94.323 or $1 (as of June 19, 2026 at 2:58 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹943.23 in Kazia Therapeutics Limited (ADR) stock (as per the Rupee-Dollar exchange rate as on June 19, 2026 at 2:58 pm IST). Based on Kazia Therapeutics Limited (ADR) share’s latest price of $13.86 as on June 19, 2026 at 8:46 am IST, you will get 0.7215 shares of Kazia Therapeutics Limited (ADR). Learn more about fractional shares .

What are the returns that Kazia Therapeutics Limited (ADR) has given to Indian investors in the last 5 years?

Kazia Therapeutics Limited (ADR) stock has given -97.31% share price returns and 27.79% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?